Quantcast
Last updated on April 16, 2014 at 6:34 EDT

You: Being Beautiful Authors Mehmet Oz, MD, & Michael Roizen, MD, Call Ribose One of the Decade’s ‘Real Nutritional Heroes’

January 5, 2009

MINNEAPOLIS, Jan. 5 /PRNewswire/ — In their latest book, You: Being
Beautiful – The Owner’s Manual to Inner and Outer Beauty (Free Press, 2008),
co-authors Mehmet Oz, MD and Michael Roizen, MD refer to ribose as one of the
decade’s “real nutritional heroes” that can “turbo-charge” those who need an
energy boost. Ribose is a naturally occurring 5-carbon sugar the body uses to
stimulate the production of adenosine triphosphate (ATP) — an essential
energy compound.

Although ribose is produced by the body, this energy molecule cannot be
replenished fast enough during certain times of demanding exercise, stress, or
as a result of many chronic diseases. When added to foods and dietary
supplements, D-Ribose enhances the body’s natural process of energy synthesis.
It reduces the loss of energy during stress, and accelerates energy and tissue
recovery and the management of free radicals.

According to Jacob Teitelbaum, MD, Medical Director of the national
Fibromyalgia and Fatigue Centers, Inc., and best-selling author of From
Fatigued to Fantastic! (Penguin Group), we are in the midst of a human energy
crisis. “We’re witnessing an emerging worldwide exhaustion epidemic,” said
Teitelbaum. “The increased stress of modern life combined with poor sleep and
nutrition is being reflected not only in the high levels of fatigue but in the
accompanying epidemic of pain currently experienced by one in four Americans
along with heart disease, the number one killer in the United States.”

Dr. Teitelbaum’s research published in the Journal of Alternative and
Complementary Medicine (12:9, 2006), found a full two-thirds of his patients
reported improvement of their symptoms in the first 12 days following a course
of Corvalen(R) D-Ribose treatment. The average improvement in energy was 45
percent and quality of life improved an average of 30 percent. Patients
reported less muscle soreness and stiffness, better ability to overcome
fatigue, as well as simply feeling better. “Supplemental Corvalen(R) is part
of a clinically proven program we’ve developed that is helping millions of
people overcome the debilitating effects of Chronic Fatigue Syndrome and
fibromyalgia as well as a general malaise of exhaustion,” said Teitelbaum.
Corvalen(R) is also used by physicians to treat congestive heart failure and
to prepare patients for off-pump bypass surgery(1).

“Bioenergy D-Ribose(TM) also has sweeping applications for healthy people
who need more energy every day,” said Raj Khankari, Ph.D., CEO of Bioenergy,
Inc. “It is already widely used as an effective training and recovery tool by
high-performance athletes. We’ve only scratched the surface on the
wide-ranging health and training benefits of this nutritional powerhouse.”

Bioenergy, Inc. — The Ribose Company(TM) — (http://www.bioenergy.com),
recently achieved GRAS (generally recognized as safe) status for D-Ribose from
the U.S. Food and Drug Administration. The privately held, Minneapolis-based
life sciences company has amassed a large body of scientific literature on the
uses of ribose for people across all age and health categories. It has more
than 40,000 customers for its proprietary Corvalen(R) products alone, and
millions worldwide use Bioenergy D-Ribose(TM) in other functional foods like
energy bars (Detour, FastFuel, Marathon) and beverages (SoBe Adrenaline Rush,
Vitamin Water, Snapple Antioxidant Water). Currently, Bioenergy D-Ribose(TM)
is included as an ingredient in approximately 100 products. The company’s
core technology lies in the development and commercialization of products
based on the physiological benefits of D-Ribose for health and wellness.

    (1) D. Perkowski, MD, S. Wagner, RN, A. Marcus, MD, J. St. Cyr, MD, Ph.D.,
        Saddleback Hospital, Orange Co., CA, "D-Ribose Improves Cardiac
        Indices in Patients Undergoing "Off-Pump" Coronary Arterial
        Revascularization," presented at Academic Surgical Congress, February
        2007.

SOURCE Bioenergy, Inc.


Source: newswire